Evidence map›Paper›PMID 23748566›Full record

ArticleNucleic acids research2013

Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish.

An Xiao, Zhanxiang Wang, Yingying Hu, Yingdan Wu, Zhou Luo, Zhipeng Yang, Yao Zu, Wenyuan Li, Peng Huang, Xiangjun Tong and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed
30.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 399 citations in OpenAlex.

  1. Article
  2. Targeted mutagenesis ofaBIOTECH · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. CRISPR in Nucleic Acids Research: the sequel.Nucleic acids research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Multiplex Editing of theThe CRISPR journal · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Speciation and adaptation research meets genome editing.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  19. Article
  20. Article

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

An XiaoKey Laboratory of Cell Proliferation and Differentiation of Ministry of Education, College of Life Sciences, Peking University, Beijing 100871, China.
Zhanxiang Wang
Yingying Hu
Yingdan Wu
Zhou Luo
Zhipeng Yang
Yao Zu
Wenyuan Li
Peng Huang
Xiangjun Tong
Zuoyan Zhu
Shuo Lin
Bo Zhang
University of California, Los Angeles · USPeking University · CN

Funding

NIDDK NIH HHS DK54508
6 · The paper itself

Abstract

Customized TALENs and Cas9/gRNAs have been used for targeted mutagenesis in zebrafish to induce indels into protein-coding genes. However, indels are usually not sufficient to disrupt the function of non-coding genes, gene clusters or regulatory sequences, whereas large genomic deletions or inversions are more desirable for this purpose. By injecting two pairs of TALEN mRNAs or two gRNAs together with Cas9 mRNA targeting distal DNA sites of the same chromosome, we obtained predictable genomic deletions or inversions with sizes ranging from several hundred bases to nearly 1 Mb. We have successfully achieved this type of modifications for 11 chromosomal loci by TALENs and 2 by Cas9/gRNAs with different combinations of gRNA pairs, including clusters of miRNA and protein-coding genes. Seven of eight TALEN-targeted lines transmitted the deletions and one transmitted the inversion through germ line. Our findings indicate that both TALENs and Cas9/gRNAs can be used as an efficient tool to engineer genomes to achieve large deletions or inversions, including fragments covering multiple genes and non-coding sequences. To facilitate the analyses and application of existing ZFN, TALEN and CRISPR/Cas data, we have updated our EENdb database to provide a chromosomal view of all reported engineered endonucleases targeting human and zebrafish genomes.

Indexed as

Chromosome DeletionChromosome InversionInverted Repeat SequencesAnimalsDatabases, GeneticEndodeoxyribonucleasesGenetic EngineeringGenetic LociGenomeMicroRNAsProteinsRNA, Small UntranslatedZebrafishEndodeoxyribonucleasesMicroRNAsProteinsRNA, Small Untranslated

Identifiers

PMID23748566
PMCPMC3737551
OpenAlexW1999903619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.